Investment
Features
FeesSafety
Academy
More
Pluang+

New patent for AI-run microcities aims to safely integrate humans and AI in veteran-focused communities.

Others
05 Jul 2026
Veterans First For America
View Source
Neutral
New patent for AI-run microcities aims to safely integrate humans and AI in veteran-focused communities.

Inventors have filed a patent for the QAIAx TDC Model Code, establishing strict safety rules and a certification program for workers in AI-managed microcities housing 1,500 to 15,000 residents. This project, part of an NIH clinical trial, tests safe human-AI collaboration, especially benefiting military veterans with housing and medical care. The system uses a 90/10 hybrid workforce model where AI handles most city functions autonomously, while licensed humans oversee critical decisions. Advanced security features include quantum-computer-based key protection and strong data privacy measures. Enrollment for the trial opens mid-August 2026, aiming to support up to one million people.

More News

Medical Informatics Corp. opens Sickbay Demo Center at Texas Medical Center to enhance patient care with real-time data integration.

Medical Informatics Corp. opens Sickbay Demo Center at Texas Medical Center to enhance patient care with real-time data integration.

Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...

Others
Bullish
52 minutes ago
Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...

Company Fundamentals
Neutral
1 hour ago
Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...

Company Fundamentals
Bullish
1 hour ago
Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
2 hours ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App